Morocco: ‘Right to health’ coalition demands transparent EU-FTA negotiations in the interest of public health
As EU-FTA negotiations resume, Moroccan civil society is uniting to raise the alarm about the threat to access to cheaper...
African treatment advocates call on ViiV Healthcare to unlock access to dolutegravir for North Africa now
On 1 December 2015 in Harare , at the International Conference on AIDS and STIs in Africa (ICASA), treatment advocates...
Chronology of access to medicine campaign in Thailand
The fight for access to medicines in Thailand centers around the use of compulsory licensing on three drugs. The chronology on...
How to reach 90-90-90 in Ukraine
Today, 3 December 2015, the All-Ukrainian Network of People Living with HIV (the Network) hosted a roundtable meeting to explore...
Defending Argentina’s public health from unmerited patents
Fundación Grupo Efecto Positivo defends Argentina’s public health from the abusive patents by multinational pharmaceutical companies Fundación Grupo Efecto Positivo...
Breaking the Vicious Cycle of Fear
This article highlights role of the US and major pharmaceutical companies to undermine trade agreements, intended to protect national interests and public health.
UNAIDS “4th 90”: Affordability of Medicines
UNAIDS has seen Argentina’s proposal to add a 4th “90” to its 90-90-90 strategy as a model to be implemented...
Argentine Government Buys Generic Version of HIV Drug
Civil society clear way for generic version of critical HIV medicine into Argentine health system Fundación Grupo Efecto Positivo (FGEP)...
Patent opposition for Sofosbuvir requested in Argentina
Organizations of people with hepatitis C are challenging a patent application that, if successful, would prevent 800,000 people having access to treatment in Argentina.
Opportunities to Overcome Patent Barriers in Ukraine
The All-Ukrainian Network of People Living with HIV brought together representatives from Indian and Ukrainian generic drug manufacturers to discuss...